Jan 25, 2017
- Fourth-quarter GAAP EPS from continuing operations of $0.51; adjusted EPS from operations of $0.65
- Issues EPS outlook for 2017, reflecting double-digit growth at the mid-point
- Completed acquisition of St. Jude Medical, creating a premier medical device business with leading positions in several large and high-growth areas